2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Epidemiology
Cancerous diseases are the most serious public health problem, posing a significant clinical burden, disrupting societal standards, and draining vast amounts of financial resources. The study of the distribution and determinants of the likelihood of cancer development is known as cancer epidemiology. Cancer epidemiology can be used to find out what causes an increase or decrease in cancer incidence in a specific community. The aim is to discover causative factors in order to develop disease-prevention techniques. Epidemiologic assessment offers the doctor with a quantitative assessment of cancer risk, lays forth the foundation for high-risk population screening modalities, and assesses the success of any preventative intervention. A thorough understanding of cancer epidemiology gives crucial information on potential causes and population patterns, allowing for the development of timely and effective health-care interventions targeted at building effective policies for prevention, screening, and diagnosis.
- Frequency of malignant diseases
- Descriptive Epidemiology
- Analytic epidemiology
- Clinical epidemiology
- Cancer epidemiology during COVID-19
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China